fingolimod hydrochloride has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 2 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Trials (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) | Recent Studies (post-2010) (benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 1,897 | 0 | 411 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kongkanand, A; Matsumiya, K; Nishimura, K; Nonomura, N; Okuyama, A; Permpongkosol, S; Takahara, S; Tsujimura, A; Wang, JD | 1 |
Hu, R; Li, SC; Li, YC; Liao, AJ; Liu, ZG; Wu, B; Yang, W; Yao, K | 1 |
2 other study(ies) available for fingolimod hydrochloride and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
Article | Year |
---|---|
Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis.
Topics: Adenocarcinoma; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Cycle; Cell Cycle Proteins; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Fingolimod Hydrochloride; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Kinetics; Male; MAP Kinase Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mitogens; p38 Mitogen-Activated Protein Kinases; Propylene Glycols; Prostatic Neoplasms; Protein-Tyrosine Kinases; Signal Transduction; Sphingosine; Tumor Cells, Cultured | 2002 |
[Mechanisms of Apoptosis Induced by FTY720 in Multiple Myeloma Cell Line U266].
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Fingolimod Hydrochloride; Humans; Inhibitor of Apoptosis Proteins; Multiple Myeloma | 2015 |